Rense Buijvoets/LinkedIn
May 26, 2026, 14:23
Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?
Rense Buijvoets, Co-owner and Managing director at Sensu, shared a post on LinkedIn:
”1 in 4 deaths worldwide are caused by thrombosis.
What if blood clots could be targeted directly at their source?
TGD001, TargED’s fusion protein in development, binds to blood clots so it can act where it is needed most. By activating plasmin locally, it helps break down VWF and fibrin, allowing the clot to dissolve and blood flow to return.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 03:54Jennifer Trowbridge: How Mutant Blood Stem Cells Use Inflammation to Drive Their Own Expansion
-
Oct 19, 2026, 03:39Wyenona Hicks: Catching Up With Old Friends and New Colleagues at AABB 2026
-
Oct 19, 2026, 03:33Developing a Non-Invasive Treatment for Life-Threatening PE – University of Michigan College of Engineering
-
Oct 19, 2026, 03:28Jim Hoffman: How NETs Contribute to Gallstone Formation and Growth
-
Oct 19, 2026, 03:28Nicolas Hubacz: The Organized Chaos of Mitochondria
-
Oct 19, 2026, 03:02Neda Horvacki: Using ROTEM to Refine Transfusion Decisions in Acute Trauma
-
Oct 19, 2026, 02:45Diego Escarraman Martinez: MATTERs Study – When a Cohort Gave Us Major Clues about TXA in Trauma
-
Oct 19, 2026, 02:35Brian O Mahony: Promoting Physical Activity and Sport in Haemophilia Care
-
Oct 19, 2026, 02:35Malusi Mtetwa: Tranexamic Acid – What Does the Evidence Tell Us?